SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock price approaches all-time highs, fueled by optimism surrounding its robotaxi strategy and potential battery expansion in Europe. The community is actively debating the stock's valuation, particularly its P/E ratio, and whether it can sustain these levels. Bullish sentiment is strong, with many anticipating further gains, while bears warn of a potential pullback.

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY is trending as community members rally around its strong cult following and meme-driven identity on the Solana blockchain. Despite market volatility, the community emphasizes their conviction and dedication to building a lasting presence. Discussions highlight the potential for significant growth and the unique culture surrounding $LENNY.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around the return of "OG Memes" and 2021 vibes, fueled by bullish sentiment following recent market events. Community members are actively promoting its strong community, potential exchange listings, and the revival of Rage Comics, emphasizing the importance of conviction and bag-working in the current market. Discussions also focus on onboarding 1 million users to crypto via their community.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending as retail traders discuss a potential short squeeze, with some comparing it to previous high-flying stocks and urging others to hold firm against perceived short manipulation. Bullish sentiment revolves around the company's prospects in the robotics sector, while others point to risks associated with low float and potential dilution. Community members are actively debating entry and exit strategies amid the volatility.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors analyze its strategic shift towards weight loss drugs after recent dealmaking, with community discussions focusing on the potential valuation upside if the company successfully delivers an oral GLP-1 pill. A large short interest adds squeeze potential should positive clinical data emerge, while some traders are eyeing actionable trade alerts and call options. However, a lowered 2025 revenue outlook has tempered enthusiasm, leading to debates about management and the stock's long-term prospects.

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

DBV Technologies - ADR

DBV Technologies

DBV Technologies is trending due to positive Phase 3 trial results for its VIASKIN Peanut patch, showing significant success in treating peanut allergies in children. Community discussions revolve around the potential for FDA filing and the long-term implications for peanut allergy desensitization. Some traders are looking at shorting it while others talk about the potential gains.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending following positive registrational phase II study results for its CAR T therapy in stiff person syndrome, with analysts raising target prices. Community members are actively discussing the potential for a bidding war or buyout, along with the possibility of a marketed secondary offering. The surge in price and volume has traders weighing whether this is a biotech breakout or just the beginning.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as silver prices surge, driving speculation about upcoming earnings and the potential for a significant breakout. Community members are closely watching technical indicators and the gold-to-silver ratio, anticipating a substantial move higher. Discussions also include potential impacts from industrial demand and broader macroeconomic factors affecting precious metals.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor ($NVTS) is trending amidst community speculation about a potential short squeeze and anticipation of news or partnerships, particularly with Nvidia ($NVDA). Discussions also highlight the stock's consolidation pattern and potential for a breakout, with some investors citing a high short interest and recent partnerships as bullish signals despite concerns over insider selling and market manipulation. Some see it as an undervalued AI play, while others worry about market conditions or potential insider sales.

Chevron Corp. engages in the provision of administrative, financial management, and technology support for energy and chemical operations. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending amid discussions around its Q2 earnings expectations and recent activities, including the completion of the Hess acquisition and potential shale gas deals in Algeria. Community members are weighing the impact of these factors, along with broader market dynamics like oil prices and geopolitical tensions, on Chevron's future performance and dividend payouts. Some are also discussing technical analysis and potential trading strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 30,011 Shares

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 30,011 shares of BridgeBio Pharma stock in a transaction dated Monday, December 15th. The stock was sold at an average price...

Castleark Management LLC Cuts Position in BridgeBio Pharma, Inc. $BBIO

Castleark Management LLC trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 27.2% in the second quarter, according to its most recent disclosure with the...

Gilder Gagnon Howe & Co. LLC Boosts Stake in BridgeBio Pharma, Inc. $BBIO

Gilder Gagnon Howe & Co. LLC grew its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 280.7% in the 2nd quarter, according to its most recent disclosure with the...

Eventide Asset Management LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO

Eventide Asset Management LLC cut its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 27.8% during the second quarter, according to its most recent Form 13F filing with the...

Frontier Capital Management Co. LLC Sells 233,538 Shares of BridgeBio Pharma, Inc. $BBIO

Frontier Capital Management Co. LLC lowered its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 30.4% during the 2nd quarter, according to the company in its most recent disclosure...

BridgeBio Pharma (NASDAQ:BBIO) CAO Maricel Apuli Sells 2,000 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an average price of $74.26...

HighVista Strategies LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO

HighVista Strategies LLC raised its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 45.2% during the second quarter, according to its most recent disclosure with the Securities and...

BridgeBio Pharma (NASDAQ:BBIO) CAO Sells $148,520.00 in Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of BridgeBio Pharma stock in a transaction that occurred on Monday, December 8th. The shares were sold at an...

Stempoint Capital LP Reduces Stock Holdings in BridgeBio Pharma, Inc. $BBIO

Stempoint Capital LP cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 73.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange...

89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd

WINTON GROUP Ltd bought a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought...

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.72	--	--	N/A
Q3 '25	-$0.91	-$0.95	-4.71%	MISSED
Q2 '25	-$0.79	-$0.95	-19.73%	MISSED
Q1 '25	-$0.92	-$0.88	4.13%	BEAT
Q4 '24	-$1.12	-$1.40	-24.98%	MISSED

BBIO
BridgeBio Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest BBIO News

BBIOBridgeBio Pharma Inc